Biotest Future Growth
Future criteria checks 0/6
Biotest's revenue and earnings are forecast to decline at 4.8% and 75% per annum respectively while EPS is expected to decline by 74.4% per annum.
Key information
-75.0%
Earnings growth rate
-74.4%
EPS growth rate
Biotechs earnings growth | 28.3% |
Revenue growth rate | -4.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 712 | 59 | N/A | N/A | 1 |
12/31/2024 | 636 | -4 | N/A | N/A | 1 |
3/31/2024 | 783 | 177 | -10 | 23 | N/A |
12/31/2023 | 685 | 127 | -36 | -3 | N/A |
9/30/2023 | 656 | 91 | -122 | -93 | N/A |
6/30/2023 | 511 | -38 | -146 | -117 | N/A |
3/31/2023 | 517 | -47 | -127 | -98 | N/A |
12/31/2022 | 516 | -32 | -70 | -40 | N/A |
9/30/2022 | 505 | -69 | -4 | 14 | N/A |
6/30/2022 | 511 | -65 | 30 | 49 | N/A |
3/31/2022 | 512 | -54 | 51 | 69 | N/A |
12/31/2021 | 516 | -63 | 16 | 34 | N/A |
9/30/2021 | 514 | -28 | -3 | 24 | N/A |
6/30/2021 | 507 | -33 | -32 | -5 | N/A |
3/31/2021 | 507 | -35 | -49 | -22 | N/A |
12/31/2020 | 484 | -31 | -44 | -17 | N/A |
9/30/2020 | 466 | -34 | -74 | -40 | N/A |
6/30/2020 | 459 | -24 | -83 | -49 | N/A |
3/31/2020 | 439 | -15 | -70 | -36 | N/A |
12/31/2019 | 419 | -5 | -68 | -34 | N/A |
9/30/2019 | 406 | -9 | -74 | -19 | N/A |
6/30/2019 | 395 | -3 | -61 | -6 | N/A |
3/31/2019 | 390 | -6 | -81 | -26 | N/A |
12/31/2018 | 400 | -13 | -105 | -50 | N/A |
9/30/2018 | 405 | 18 | -123 | -16 | N/A |
6/30/2018 | 409 | 6 | -100 | 6 | N/A |
3/31/2018 | 400 | 1 | -92 | 15 | N/A |
12/31/2017 | 378 | -16 | N/A | 34 | N/A |
9/30/2017 | 257 | -48 | N/A | 8 | N/A |
6/30/2017 | 301 | -47 | N/A | -8 | N/A |
3/31/2017 | 340 | -29 | N/A | 35 | N/A |
12/31/2016 | 408 | 6 | N/A | 66 | N/A |
9/30/2016 | 531 | 128 | N/A | 51 | N/A |
6/30/2016 | 525 | 52 | N/A | 57 | N/A |
3/31/2016 | 526 | 36 | N/A | 44 | N/A |
12/31/2015 | 535 | 27 | N/A | 38 | N/A |
9/30/2015 | 590 | -88 | N/A | 62 | N/A |
6/30/2015 | 606 | 3 | N/A | 54 | N/A |
3/31/2015 | 602 | 16 | N/A | 15 | N/A |
12/31/2014 | 582 | 19 | N/A | -11 | N/A |
9/30/2014 | 543 | 27 | N/A | -26 | N/A |
6/30/2014 | 522 | 31 | N/A | -28 | N/A |
3/31/2014 | 504 | 30 | N/A | -1 | N/A |
12/31/2013 | 501 | 32 | N/A | -7 | N/A |
9/30/2013 | 483 | 32 | N/A | 10 | N/A |
6/30/2013 | 463 | 29 | N/A | 20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIES.F's earnings are forecast to decline over the next 3 years (-75% per year).
Earnings vs Market: BIES.F's earnings are forecast to decline over the next 3 years (-75% per year).
High Growth Earnings: BIES.F's earnings are forecast to decline over the next 3 years.
Revenue vs Market: BIES.F's revenue is expected to decline over the next 3 years (-4.8% per year).
High Growth Revenue: BIES.F's revenue is forecast to decline over the next 3 years (-4.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIES.F's Return on Equity is forecast to be high in 3 years time